Study on Veterans Reveals Real-World Survival Outcomes for Targeted Therapies in Advanced Renal Cell Carcinoma
Findings underscore the limited generalizability of clinical trial results to patients in the real world.
Brain Cancer
BRAIN CANCER ADVISOR
FEATURED CONTENT
-
-
Autoimmune Conditions and Primary CNS Lymphoma Risk
Primary central nervous system lymphoma (PCNSL) is a rare (incidence rate of 0.6 cases per 100,000 person years) non-Hodgkin lymphoma (NHL) found in the brain, spinal cord, and leptomeninges. -
Precision Medicine Transcends Tumor Type
Both DRUP and TAPUR have emphasized the importance of documenting the failures, as well as the successes, of the use of off-label therapies in cancer. -
Multitumor “Exceptional Responder” Program in Australia Seeks to Gain Clinical Context
The first multitumor exceptional responder program in Australia is under way, adding to the growing worldwide effort to identify patient DNA changes and biomarkers of response. -
Vaping Injuries Raise New Concerns About Medical Marijuana
Many recent vaping injuries have been linked to e-cigarette use of THC oils or other cannabis oil products, raising new concerns about patients with cancer who use the devices for medical marijuana.
BRAIN CANCER NEWS
Addition of Bevacizumab to Temozolomide-Based Chemotherapy Increased OR in Children With R/R Neuroblastoma
Bing-Neel Syndrome: Managing Patients With Waldenström Macroglobulinemia Characterized by CNS Involvement
Immunological Profiling of High-Grade Gliomas Reveals Subtypes That Influence Survival
Treatment Reduction in Intermediate-Risk Neuroblastoma Deemed Successful
Outcomes Poor Years After Radiation for Pediatric Glioma Survivors
Want to read more?
Please login or register first to view this content.
